Welltower Inc
Q2 2025 Earnings
Market Reaction
S&P 500 over the same 30 days: +2.15%.
Did WELL Beat Earnings? Q2 2025 Results
Welltower delivered a standout second quarter for 2025, with total revenue climbing 42.1% year-over-year to $2.55 billion — beating the $2.49 billion consensus estimate by 2.49% — as the healthcare REIT's Seniors Housing Operating portfolio emerged as the clear engine of growth. The SHO segment posted 23.4% same-store NOI growth, driven by 420 basis points of year-over-year occupancy improvement and 4.9% RevPOR growth that meaningfully widened margins, with shares having gained over 43% in the past year reflecting sustained investor confidence in the platform. Normalized FFO reached $1.28 per diluted share, up 21.9% year-over-year, while net income attributable to common stockholders came in at $0.45 per diluted share. The company's balance sheet also strengthened materially, with net debt to adjusted EBITDA tightening to 2.93x from 3.68x a year ago. Management raised full-year 2025 normalized FFO guidance to $5.06–$5.14 per diluted share and lifted the quarterly dividend 10.4% to $0.74 per share, signaling confidence in durable cash flow growth ahead — a profile that has attracted attention among <a href="https://247wallst.com/investing/2025/06/21/4-bofa-securities-strong-buy-growth-10-stocks-also-pay-reliable-dividends/">dividend-paying growth stocks</a>.
- SHO portfolio SSNOI growth of 23.4% driven by 420 bps occupancy improvement and 4.9% RevPOR growth
- RevPOR growth meaningfully outpacing ExpPOR growth, expanding SSNOI margin by 330 bps
- Total portfolio SSNOI growth of 13.8%
- Active capital deployment with $9.2 billion pro rata investment activity year-to-date
- Net Debt to Adjusted EBITDA improved to 2.93x from 3.68x year-over-year
Forward Guidance & Outlook
Welltower raised its full-year 2025 guidance. Net income attributable to common stockholders is now expected at $1.86-$1.94 per diluted share (previously $1.70-$1.84). Normalized FFO guidance was raised to $5.06-$5.14 per diluted share (previously $4.90-$5.04). Average blended SSNOI growth is expected at 11.25%-13.25%, with SHO at approximately 18.5%-21.5%, Seniors Housing Triple-net at 3.5%-4.5%, Outpatient Medical at 2.0%-3.0%, and Long-Term/Post-Acute Care at 2.0%-3.0%. G&A expenses are anticipated at $243-$249 million with stock-based compensation of approximately $52 million. Additional development funding of $212 million is anticipated for 2025 on projects underway. Pro rata disposition proceeds of $340 million are expected over the next twelve months at a blended yield of 6.9%.
WELL YoY Financials
WELL Revenue by Segment
WELL Revenue by Geography
Figures from SEC filings and company reports. Not investment advice.